Peak Financial Advisors LLC Buys Shares of 14,462 Colgate-Palmolive (NYSE:CL)

Peak Financial Advisors LLC purchased a new position in shares of Colgate-Palmolive (NYSE:CL) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 14,462 shares of the company’s stock, valued at approximately $1,315,000.

Other institutional investors have also modified their holdings of the company. Wealthspire Advisors LLC lifted its position in Colgate-Palmolive by 3.0% in the 2nd quarter. Wealthspire Advisors LLC now owns 3,853 shares of the company’s stock valued at $374,000 after acquiring an additional 111 shares in the last quarter. Oppenheimer Asset Management Inc. raised its stake in shares of Colgate-Palmolive by 2.5% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 27,860 shares of the company’s stock valued at $2,704,000 after purchasing an additional 678 shares during the period. Envestnet Asset Management Inc. lifted its holdings in shares of Colgate-Palmolive by 16.2% in the second quarter. Envestnet Asset Management Inc. now owns 459,445 shares of the company’s stock valued at $44,585,000 after purchasing an additional 64,123 shares in the last quarter. Angeles Investment Advisors LLC acquired a new position in shares of Colgate-Palmolive during the second quarter worth about $242,000. Finally, Dimensional Fund Advisors LP boosted its position in shares of Colgate-Palmolive by 19.2% during the second quarter. Dimensional Fund Advisors LP now owns 3,503,450 shares of the company’s stock worth $340,006,000 after buying an additional 565,524 shares during the period. Institutional investors own 80.41% of the company’s stock.

Insider Transactions at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.37% of the company’s stock.

Colgate-Palmolive Price Performance

NYSE:CL opened at $87.73 on Wednesday. The company has a market cap of $71.68 billion, a P/E ratio of 25.14, a P/E/G ratio of 3.31 and a beta of 0.44. The firm’s fifty day moving average price is $92.36 and its two-hundred day moving average price is $97.92. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.28%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. Wells Fargo & Company cut their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Piper Sandler cut their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. JPMorgan Chase & Co. increased their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. TD Cowen lowered their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Finally, Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price target for the stock from $105.00 to $101.00 in a research report on Monday, October 28th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, Colgate-Palmolive currently has an average rating of “Hold” and an average target price of $103.63.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.